{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T18:20:35Z","timestamp":1791483635074,"version":"4.3.4"},"reference-count":23,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2006,6,6]],"date-time":"2006-06-06T00:00:00Z","timestamp":1149552000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2006,8]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Objective\u2002<\/jats:bold> To identify the predictors of successful antibiotic prophylactic treatment using benzathin\u2010penicillin\u00a0G to prevent recurrence of erysipelas in patients with secondary upper limb lymphoedema.<\/jats:p><jats:p><jats:bold>Design\u2002<\/jats:bold> A retrospective cohort study.<\/jats:p><jats:p><jats:bold>Setting and patients\u2002<\/jats:bold> Patients with secondary arm lymphoedema were recruited in a single lymphology unit between 1990 and 2003. All patients had had at least three recurrences of erysipelas. Patients were given 2.4\u00a0MU benzathin\u2010penicillin\u00a0G intramuscularly at 14\u2010day intervals. For each patient, the following data were recorded: characteristics of breast cancer treatment (type of surgery, radiotherapy, hormone therapy), number of erysipelas recurrences before inclusion, patient characteristics including body mass index (BMI) and lymphoedema volume at inclusion.<\/jats:p><jats:p><jats:bold>Main outcome measures\u2002<\/jats:bold> The outcome studied was the occurrence of erysipelas on the affected arm under antibiotic prophylactic treatment.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> With a 4.2\u2010year median follow\u2010up from the onset of antibiotic prophylactic treatment, 23 of 48 women experienced recurrence of erysipelas. The median duration of erysipelas recurrence\u2010free period under this treatment was 2.7\u00a0years. The estimated rate of recurrence was 26%[95% confidence interval (CI) 13\u201338%] at 1\u00a0year and 36% (95%\u00a0CI 22\u201350%) at 2\u00a0years. No patient stopped the treatment because of side\u2010effects. No predictive factor of erysipelas recurrence under antibiotic prophylactic treatment was identified.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> Antibiotic prophylaxis using benzathin\u2010penicillin is a well\u2010tolerated treatment of erysipelas recurrence in patients with upper limb lymphoedema secondary to breast cancer. The rate of erysipelas recurrence was 26% at 1\u00a0year in patients who had a history of at least one erysipelas. We did not find any predictor of erysipelas recurrence.<\/jats:p>","DOI":"10.1111\/j.1468-3083.2006.01648.x","type":"journal-article","created":{"date-parts":[[2006,6,6]],"date-time":"2006-06-06T10:29:57Z","timestamp":1149589797000},"page":"818-822","source":"Crossref","is-referenced-by-count":74,"title":["Recurrence of lymphoedema\u2010associated cellulitis (erysipelas) under prophylactic antibiotherapy: a retrospective cohort study"],"prefix":"10.1111","volume":"20","author":[{"given":"S","family":"Vignes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Dupuy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,6,6]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"191","article-title":"Clinical practice guidelines for the care and treatment of breast cancer: 11. Lymphedema","volume":"164","author":"Harris SR","year":"2001","journal-title":"CMAJ"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20010915)92:6<1368::AID-CNCR1459>3.0.CO;2-9"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1086\/513752"},{"key":"e_1_2_6_5_2","first-page":"84","article-title":"The diagnosis and treatment of peripheral lymphedema. Consensus document of the International Society of Lymphology","volume":"36","author":"International Society of Lymphology.","year":"2003","journal-title":"Lymphology"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9610(73)80014-5"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1053\/apmr.2001.26822"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1016522319282"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(73)80217-3"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)91123-7"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1159\/000249253"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1987.tb03728.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0163-4453(91)90898-3"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01728920"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0399-077X(05)80579-7"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1080\/00034983.1999.11813433"},{"key":"e_1_2_6_17_2","first-page":"126","article-title":"Episodic dermatolymphangioadenitis (DLA) in patients with lymphedema of the lower extremities before and after administration of benzathin penicillin: a preliminary study","volume":"29","author":"Olszewski WL","year":"1996","journal-title":"Lymphology"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.318.7198.1591"},{"key":"e_1_2_6_19_2","first-page":"163","article-title":"Role of aerobic bacteria in the aetio\u2010pathogenesis of acute adenolymphangitis (ADL) in filarial lymphoedema","volume":"33","author":"Vijayalakshmi N","year":"2000","journal-title":"Lymphology"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2883-2-4"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1997.19872068.x"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.127.4.493"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003143.pub2"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.5.1203"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-3083.2006.01648.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-3083.2006.01648.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T17:39:59Z","timestamp":1697045999000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-3083.2006.01648.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6,6]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["10.1111\/j.1468-3083.2006.01648.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-3083.2006.01648.x","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6,6]]}}}